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*is study describes a novel approach to solve the surgical site infection (SSI) classification problem. Feature engineering has
traditionally been one of the most important steps in solving complex classification problems, especially in cases with temporal data.
*e described novel approach is based on abstraction of temporal data recorded in three temporal windows. Maximum likelihood
L1-norm (lasso) regularization was used in penalized logistic regression to predict the onset of surgical site infection occurrence based
on available patient blood testing results up to the day of surgery. Prior knowledge of predictors (blood tests) was integrated in the
modelling by introduction of penalty factors depending on blood test prices and an early stopping parameter limiting the maximum
number of selected features used in predictive modelling. Finally, solutions resulting in higher interpretability and cost-effectiveness
were demonstrated. Using repeated holdout cross-validation, the baseline C-reactive protein (CRP) classifier achieved a mean AUC
of 0.801, whereas our best full lassomodel achieved ameanAUCof 0.956. Bestmodel testing results were achieved for full lassomodel
with maximum number of features limited at 20 features with an AUC of 0.967. Presented models showed the potential to not only
support domain experts in their decision making but could also prove invaluable for improvement in prediction of SSI occurrence,
which may even help setting new guidelines in the field of preoperative SSI prevention and surveillance.
1. Introduction
Surgical site infections (SSIs) are the most common type of
nosocomial infections and a major cause of morbidity among
surgical patients, especially following abdominal and co-
lorectal [1], cardiovascular [2], oncological [3], and trauma or
orthopaedic surgeries [4, 5]. An empirical surveillance study
[6] for patients undergoing surgical procedures (SP) that
encompassed data from 82 hospitals in 30 countries confirmed
that the highest SSI rates from SP were from the aforemen-
tioned surgeries, where ventricular shunt had the highest rate
with 12.9%, followed by colon surgery with 9.4%, bile duct,
liver, or pancreatic surgery with 9.2%, abdominal aortic an-
eurysm repair with 7.7%, and thoracic surgery with a 6.1% rate.
*e best strategy in SSI prevention lies in effective
guidelines to the issue of SSI prevention, and most are
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specifically tailored to meet the needs of the countries in
which they were published [7]. *e World Health Orga-
nization (WHO) in 2016 published global guidelines on the
prevention of SSI [8], which included conducting specific
tests per patient prior to a certain medical procedure. *ere
are several approaches to predict occurrence and reduce the
incidence of SSIs, such as different risk models and pre-
vention strategies. For instance, high-income countries have
realized that collecting data through centralized surveillance
systems is an essential component of SSI prevention
[7, 9–11]. Risk models aim at predicting SSIs and guiding
further action to prevent more serious outcomes.
In addition to the health risk for the patient, SSI usually
implies longer postoperative hospital stays, considerably
increased postoperative costs, and often a higher mortality
(on average by 9.7 days with an increased cost of $20,842 per
admission) [12]. *e economic costs alone of SSIs are
substantial [13], for example, when looking from the na-
tional perspective (in the US), the SSI cases were associated
with additional 406,730 hospital-days and hospital costs
exceeding $900 million. An additional 91,613 readmissions
for treatment of SSI accounted for a further 521,933 days of
care at a cost of nearly $700 million [14].
Several researchers have already focused on predicting
SSI based on electronic health records (EHRs), for example,
by using patient demographics, past medical history, and
surgical information [15]. In recent studies, ranging from
model evaluation methods, such as ROC analysis [16, 17], to
data-driven modelling approaches, such as linear regression
models [1, 18, 19] and Support Vector Machines [20], the
attention has shifted to results of blood tests before and after
surgery. One of themain reasons being the ease and extent of
this type of data. Specifically, blood test results of C-reactive
protein (CRP) have been associated with a high predictive
power [1].
Interpretability of the current practices and models
therefore starts with CRP, a known indicator of inflammation,
and is the first in line of predictors associated with the
presence of inflammation of any kind, but it also has its
drawbacks. Among these is the fact that if a high CRP is
measured in a patient prior to surgery, the surgery will most
likely get postponed. Consequently, CRP is not a predictor,
but more likely a filter of having a surgery in a specific patient
at all. However, it is of course also clear that if surgery gets
underway in a patient with an already high mean CRP value,
the probability that the surgical site gets infected increases.
Several studies have taken a classical (knowledge-based)
approach and handcrafted features by setting cutoff values of
CRP after the surgery, where the term of postoperative day
(POD) is commonly used. For example, Angiolini et al. [19]
evaluated the diagnostic accuracy as an early predictor of
SSIs after pancreaticoduodenectomy and showed that CRP
on POD 3, with a cutoff of 17.27mg/dl, predicted the
postoperative course in 78.2% of patients, whereas a CRP
cutoff of 14.72mg/dl on POD 4 predicted the postoperative
course in 80.2% of patients. A systematic review of studies on
diagnostic value of CRP after major abdominal surgery for
predicting SSI [21] showed that CRP> 15.9mg/dl on POD 3
increases the risk of SSI [10].
An alternative data-driven approach for the SSI problem
was demonstrated by Ke et al. [22], where the focus was on
dynamic wound data (e.g., using mHealth tools, which in-
clude self-reported symptoms of pain, body temperature,
wound features, and patient- or caregiver-generated images
of the wound) for SSI prediction. Predicting time to SSI
onset with spatial-temporal data via bilinear formulation
was used and further enhanced with automatic missing data
imputation by the matrix completion technique for data
from POD 2 until discharge or POD 21, whichever was
earlier.*is approach showed superior performance on real-
world data set of SSI in terms of mean absolute error (MAE)
compared to linear regression and support vector regression
(SVR) [22]. *e aforementioned studies have all focused on
postoperative data. However, as Silvestre et al. [18] noted,
preoperative CRP concentrations were significantly higher
already prior to surgery in patients that developed infections
postoperatively than those who did not develop complica-
tions. *is suggests that there is a high risk that an un-
derlying infection was already present prior to surgery.
Hence, if we detect those patients prior to surgery, pre-
ventive interventions can be performed, minimizing the risk
of SSI. We believe that a data-driven approach that alleviates
the vast amounts of information stored in the EHRs, and in
particular in blood samples, is valuable for predicting SSI
prior to surgery. Such an approach already achieved re-
markable success rates at predicting development of SSIs
following gastrointestinal surgery [20].
Predicting SSI after surgery gives us additional intra- and
postoperative risk factors such as surgery duration [23–25],
treatment complexity [25], blood loss during surgery [24],
administration of supplemental oxygen [26], and higher
intraoperative lactate levels [23] which in turn can improve
the SSI prediction or augment an existing preoperative data
SSI prediction.
We further summarized our findings of studies focusing
on pre- and/or postoperative data in the prediction of SSI in
Table 1, where we compared tasks, data, and methods used.
We conjecture that a higher predictive power lies in the
expansion of the preoperative blood test results from the
mean value to more complex parameters (e.g., slope of linear
regression line for a fixed temporal window and number and
proportion of low/high abnormal values of tests for a fixed
temporal window). *is presents a unique approach, which
was to our best knowledge, not yet used in SSI prediction.
Considering the available models for predicting SSI
based on preoperative data, our motivation was to improve
their predictive potential, while at the same timemaximizing
their interpretability and final diagnostic cost-effectiveness.
As such, this study presents a novel approach to SSI pre-
diction among patients undergoing gastrointestinal surgery
based on temporal data from blood test results. Our solution
is built on the abstraction of preoperative blood test data in
three different temporal windows. In order to maintain
interpretability, penalized logistic regression was used as a
core classificationmethod since it allows tuning of the model
complexity to avoid overfitting and still maintains a high
level of predictive performance. Moreover, clinical knowl-
edge was incorporated into the model, and also features that
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Table 1: Summary table of articles focused on pre- and/or postoperative data in the prediction of SSI.




Use of CRP identifies postoperative
infectious complications in patients
undergoing colorectal surgery
Blood tests: CRP, neutrophil-to-
lymphocyte ratio (NLR), and white
blood cell (WBC)
Postoperative
(2 POD) Multiple linear regression
Dutta et al. [16]
Examine WCC, albumin, and CRP
following esophagogastric cancer
resection as a predictor of
postoperative surgical site infectious
complications
Blood tests: White cell count





test on medians and
ranges
Platt et al. [17]
Analyze postoperative WCC,
albumin, and CRP and their
diagnostic accuracy in case of
infectious complications.










Assess the value of serum CRP and
PCTtime course in the postoperative
setting of elective colorectal surgery
with primary anastomosis and its
potential in detecting infectious
postoperative complications.










Prediction of SSI with individual
blood tests and in a joint model
considering linear and nonlinear
classifiers, both before and after
surgery
Blood tests: hemoglobin, leucocytes,
CRP, potassium, sodium, creatinine,








Gans et al. [21] Systematic review
Ke et al. [22]
*e use of dynamic wound data for
SSI risk prediction is explored, by
exploiting the low-rank property of
the spatial-temporal data via the
bilinear formulation
Procedure related data as well as
clinical data such as smoking,










*e authors investigated the risk
factors for SSI in patients who had
undergone appendectomy
Blood tests such as CRP, albumin,
NLR; the length of the operation, the
number of intra-abdominal drains,
the term of antibiotic use, the
hospital stay, among others; also,
clinical background features were
considered
Preoperative





*e aim of this study was to look for
a relationship between the fatty
tissue metabolism measured by
adipocytokine levels and the risk of
postoperative infection
Blood tests: preoperative plasma
levels of eight adipocytokines,
cholesterol, triglycerides, insulin,
and CRP; furthermore, patient-
specific and intraoperative risk








coefficients, and the odds
ratios
Mohri et al. [29]







Blood tests: white cell count,
hemoglobin, albumin, CRP;
furthermore, age, sex, tumor site,










Moyes et al. [30]
*e aim was to examine the
relationship between the
preoperative mGPS (the glasgow




resection for colorectal cancer
Blood tests: white cell count,
albumin, and C-reactive protein and
clinicopathological characteristics
such as age, gender, tumor site, and
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account for the amount of missing data were proposed.
Additional solutions were developed to produce a more
cost-effective model by introducing a penalization based on
the price of the respective blood tests. Using this approach, it
is possible to achieve better economic efficiency of the
models in practice as our approach aims to reduce the costs
of laboratory tests by eliminating more expensive tests in
cases where similar results can be achieved by combining
tests costing less.
2. Materials and Methods
2.1. Data Set Description. *e data used in this work was
previously explored and analyzed by Soguero-Ruiz et al.
[20]; further, it was used in the American Medical In-
formatics Association Knowledge Discovery and Data
Mining 2016 data competition. *e data set we considered
consists of 7725 patients that underwent a gastrointestinal
surgical procedure at the University Hospital of North
Norway in the years 2004–2012. Since SSI-persistent in-
hospital morbidity is particularly associated with colorectal
cancer surgery [33], patients who did not undergo this type
of surgery were excluded, reducing the size of the cohort to
1137 patients. Guided by input from clinicians, the In-
ternational Classification of Diseases (ICD10) and
NOMESCO Classification of Surgical Procedures (NCSP)
codes related to severe postoperative complications, and in
particular to SSI, were considered to identify patients with
SSI. Patients who did not have these codes or the word
“infection” in any of the postoperative text documents were
considered as controls. 80% of the cohort (909 patients) was
used for model development, and the remaining 20% of the
cohort was set aside for model testing. In the model de-
velopment set, 183 out of 909 patients (20.13%) developed
SSI, whereas in the test set 50 out of 228 (21.93%) patients
developed SSI.
Data included information from various blood tests (811
different blood tests at different points in time). *e data
ranging from preoperative day 5393 up to the day of surgery
were used, while data collected postoperatively were not
used in this study. For each blood test, the mean number of
blood test values recorded in the last 30 days before the
surgery was calculated. In total, 14 most frequent blood tests
(with a mean number of measurements above one) were
used: hemoglobin (5.37 measurements), leukocytes (4.43),
sodium (4.24), CRP (4.11), potassium (3.97), albumin (2.87),
creatinine (1.94), thrombocytes (1.53), alanine amino-
transferase (ALT, 1.23), total bilirubin (1.22), aspartate
aminotransferase (AST, 1.14), glucose (1.06), amylase (1.06),
and alkaline phosphatase (ALP, 1.04). From a medical point
of view, the abovementioned blood tests can have a specific
or a more general role in the context of gastrointestinal
surgery. ALT, AST, ALP, total bilirubin, and albumin serve
to specifically assess hepatic functional capacity, in-
flammation or biliary tract obstruction, and amylase pan-
creatic ductal obstruction and inflammation. Glucose is a
much more general metabolic marker, depending heavily on
insulin sensitivity in peripheral tissues, but may be of special
relevance in gastrointestinal patients with liver or pancreatic
disease, due to deranged central insulin sensitivity or re-
duced gluconeogenesis, and diminished insulin secretion,
respectively. *e remaining 7 tests are even less specific for
gastrointestinal conditions. Reduced hemoglobin may in-
dicate chronic gastrointestinal bleeding, elevated CRP, and
leukocytes inflammation. Sodium, potassium, and creatinine
levels help to assess water and electrolyte balance and kidney
function, and thrombocytes the risk for bleeding or
thrombosis [34–36].
Some of these represent parameters obtained in routine
blood tests, while others are more specifically aimed at
detecting inflammation or infection, making them easier to
interpret in the context of SSI model prediction.
2.2. Feature Representation. Following an initial exploratory
analysis of model development data set using different vi-
sualization techniques (observing different patterns with
regard to SSI), we set the observation interval to 60 days
before the surgery for all selected blood test based features.
*e initial data set of feature representation thus consisted of
14 most frequent blood tests for an interval of 60 days before
surgery on a daily basis, where the mean values of blood tests
were used if more than one value was recorded in a day.
Since all tests were not available on a daily level, with a large
percentage of missing values ranging from 90.25% for he-
moglobin to 98.19% for amylase present, imputation using
three approaches was used: (a) last observation carried
forward (LOCF) [37], (b) k-nearest neighbours (KNN) [38],
Table 1: Continued.
Article Task Data Preoperative/postoperative Method
Cappabianca
et al. [31]
*e study objective was to evaluate
the effect of CRP on short-term and
midterm outcome after cardiac
surgery
Preoperative patient profile,
including features such as diabetes,
body mass index, and smoking
history, among others; this type of
surgery was also considered
Pre- and
postoperative
χ2 test, shapiro–Wilk test,
kaplan–meier curves, and
the log-rank test, logistic
regression and cox model
Mujagic et al.
[32]
*is study examines the association
between preoperative biochemical
markers and the risk of SSI
Blood tests: hemoglobin, creatinine,
albumin, CRP, and white blood cell
count; and other baseline features




Fisher’s exact test, t-test,
kruskal-Wallis test,
logistic regression
4 Computational and Mathematical Methods in Medicine
and (c) a combination of LOCF and KNN, where LOCF was
used for the farthest time point, i.e., 60 days before surgery
and KNN elsewhere. *e last approach enabled us to benefit
both from the addition of patient history for patients who
did not have certain blood tests 60 days before surgery with
LOCF and the imputation of results based on the non-
missing values of the neighbours with KNN.
Additionally, three temporal windows (S, short; M, me-
dium, and L, long) were manually defined for each feature
based on the observed patterns (e.g., peaks or changes in
trends) of feature values prior to surgery in (Figure 1). *e S
window included measurements from days 2 to 0 (depending
on observed pattern for specific blood test) prior to surgery, in
which the most tests per day were performed. *e M window
included data from days 18 to 13 prior to surgery up to the
start of the S window.*e L window encompassed the period
from preoperative day 60 to the upper limit of window M.
Since the length of the observation interval could in-
fluence the SSI prediction results, we included shorter ob-
servation intervals, more specifically a 30-day and 15-day
observation interval. In the 30-day observation interval, the
L window encompassed a shorter temporal window from
preoperative day 30 to the upper limit of windowM.*e 15-
day observation interval had 1 temporal window from 15 to
0 days before surgery.
While changes in blood test values in the short temporal
window can be associated with acute infections in patients
prior to surgery (that can clearly lead to SSI after surgery),
the longer temporal windows (medium and long) are more
indicative of some underlying (maybe even not properly
treated) pathophysiological changes that could have an
indefinite influence on the SSI outcome. Looking at the
parameters that were chosen by ourmodel to predict SSI, it is
clear that the different temporal windows play an important
part in the battery of predictors for SSI.
*e following features were extracted for each temporal
window separately:
(i) Mean value for each set of blood test measurements.
(ii) Slope of the simple linear regression for each set of
blood test measurements (representing the trend).
(iii) *e number of measurements for each blood test
(calculated before imputation).
(iv) Proportion of measurements in current window,
calculated as the number of measurements in
current window divided by the number of all
available measurements in 60, 30, or 15 days before
the surgery for each patient (calculated before
imputation).
(v) Number of abnormal (high and low) blood test
values for each blood test as defined in Norwegian
National Guidelines [39] (calculated before
imputation).
(vi) Proportion of high/low abnormal values, calculated
as the number of high/low abnormal values for each
blood test divided by the number of all blood test
values recorded in different temporal windows
(calculated before imputation). *ese features were
introduced as an early indicator for developing SSI,
with our underlying assumption that patients with a
higher proportion of abnormal blood tests develop
SSI more frequently.
Since there were 14 blood tests and 3 temporal windows
available for each of the three types of generated features,
with 6 features generated in each instance, the final datasets
consisted of 252 features for the 60-day and 30-day ob-
servation interval and 84 features for the 15-day observation
interval.
2.3. Predictive Modelling. As maximizing interpretability
was one of our goals, we restricted modelling to linear
models with an additional model based on an ensemble of
boosted decision trees serving as a nonlinear comparison.
We further restricted linear models to regularized linear
models allowing the complexity of the model to be tuned for
a better predictive performance, thus avoiding overfitting.
A generalized linear model via penalized maximum
likelihood L1-norm (lasso) regularization was used as de-








wil yi, β0 + β
T
xi􏼐 􏼑 + λβ1, (1)
where i represents observations and its negative log-
likelihood contribution is noted as l(y, η), wi noting
weights and tuning (shrinkage) parameter λ controlling the
overall strength of the penalty. We excluded a broader elastic
net regularization, as it did not show any significant gain in
our initial experiments and added complexity to the model,
making it less interpretable.
Due to the class imbalance with only 20.13% positive
cases in the development set, random oversampling ex-
amples (ROSE) [41] technique was used.
Additionally, a prior knowledge of predictors (blood
tests) was integrated in the modelling by introduction of
penalty factors for each coefficient βj, j � 1, . . . , p, which
depended on blood test prices (these vary from test to test,
with the most expensive costing twice the price of the
cheapest one; Table S1).*e penalty term can be described as











where vj represents the penalty factor of coefficient j.
An additional user-defined parameter pmax was used in
the above-described framework to limit the parameter λ in a
way that the maximum number of selected features in the
model cannot exceed pmax. *is parameter can be seen as an
“early stopping” parameter, as it stops the λ cross-validation
tuning as soon as the number of selected features exceeds
pmax, thus providing a much higher level of interpretability
and generalizability of the model. To compare results with a
nonlinear-based solution, an optimized tree learning-based
distributed gradient boosting framework called XGBoost
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[42] was used with the full set of 252 features. Selection of
parameters for it was done by selecting the best performing
set of values of parameters via 100 repeated evaluations of
random range values for parameters on ­xed training and
validation set. It has to be noted that ensemble-based models
are less interpretable and are not preferred in cases where
model explanation can be of practical use (in our case for
clinician treating the GIT surgery patient or extracting new
knowledge that could lead to new guidelines).
2.4. Cost-Ecient Feature Penalization. e prices for each
blood test were obtained from the Department of Medical
Biochemistry, Oslo University Hospital. e blood tests with
lower prices were assigned lower feature-speci­c penaliza-
tion coecients vj that were calculated as vj  rmax/rj, with
rmax representing a price of the most expensive blood test
(leukocytes and thrombocytes at 58 NOK) and rj repre-
senting a price of the blood test j. e lowest value of vj was
calculated for a group of glucose blood test-related features
(23 NOK).
3. Results
3.1. Experimental Setup. Repeated holdout cross-
validation approach on model development data set,
using 80% of data for training and 20% for validation, was
used in order to ensure the generalizability of the pre-
dictive model results. e holdout cross-validation was
repeated 100 times in each experiment to obtain mean
values and 95% con­dence intervals (CI) for each per-
formance metric (Table 2). e following widely used
performance metrics were used in all experiments (Tables
2 and 3): area under the ROC curve (AUC) as primary
evaluation metric; area under the precision recall curve
(AUPRC) as a secondary evaluation metric, since it
summarizes the PPV (i.e., ratio of correctly classi­ed
positive values to the number of all instances classi­ed as
positive) over sensitivity into one number and it can be
often more informative than AUC in cases of unbalanced
datasets [43], threshold, sensitivity, speci­city, positive
predictive value (PPV), and negative predictive value
(NPV).
e same performance metrics were also used on the test
set (n  228) to evaluate the ­nal model built on the model
development set (n  909).
3.2. Results Using Penalized Logistic Regression. Initially,
experiments using L1-penalized logistic regression (lasso)
were conducted without imposing a limit to the number of
selected features pmax in the λ cross-validation tuning step,
with di¡erent imputation methods and di¡erent observation
intervals. e results showed that when we used di¡erent
imputation methods for di¡erent observation intervals (60,
30, or 15 days), the three imputation methods (LOCF, KNN,
and the combination of LOCF and KNN) performed sim-
ilarly, more precisely AUC, AUPRC, and PPVwere generally
less than 1% apart same observation intervals and consid-
ering that the combined LOCF and KNN imputation
method often performed better in PPV we chose to be used
in further experiments. e results for LOCF and KNN
imputation for the 15-day observation interval with 1
temporal window resulted in an AUC of 0.937, AUPRC of
0.797, sensitivity of 0.832, speci­city of 0.893, and PPV of
0.668; the 30-day observation interval with 3 temporal
windows resulted in an AUC of 0.951, AUPRC of 0.812,
sensitivity of 0.852, speci­city of 0.890, and PPV of 0.665;
and the 60-day observation interval with 3 temporal win-
dows resulted in an AUC of 0.952, AUPRC of 0.810, sen-
sitivity of 0.859, speci­city of 0.899, and PPV of 0.684. We
selected the 60-day observation interval with 3 temporal
windows with LOCF and KNN imputation for further ex-
periments since AUC, AUPRC, and PPV values were the
most balanced.
ese experiments were followed by experimental runs
with di¡erent pmax values ranging from 10 to 100 in steps of
10 to ­nd the best balance between the interpretability and
predictive performance of the model. When observing the
in¥uence of relaxing the restriction on the maximum
number of features on the mean AUC, the stabilization of































































Figure 1: Selection of time windows based on visualization of 14 parameters for 909 patients during 60 days before the surgery. (a) ALAT.
(b) Albumin. (c) ALP. (d) Amylase. (e) ASAT. (f ) Bilirubin total. (g) CRP. (h) Glucose. (i) Hemoglobin. (j) Potassium. (k) Creatinine. (l)
Leukocytes. (m) Sodium. (n) rombocytes.
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Initial experiments included the use of ROSE algorithm,
where we oversampled due to class imbalance of 20.13%
positive cases, but there was a loss in terms of AUC on
average of 0.5%; therefore, we did not include rebalanced
data in further modelling.
*e first results (CRP) with an AUC of 0.797 were
obtained from a very simple (baseline) model, where only
three features representing the mean CRP value in L, M, and
S windows were used together with age and sex variables. In
the basic lasso model (BLM), only the values of the recorded
blood tests were used (mean value, slope, number, and
proportion of abnormal values for each time frame interval).
Since there were 14 blood tests and 3 time windows available
for each of the three types of generated features, the data set
consisted of 126 features. Together with age and sex, there
were 128 features available to build the BLM. As it can be
observed from Table 2, the mean AUC value for the BLM
with pmax restricted to 20 features decreased only slightly,
from 0.947 to 0.943, compared to the unrestricted model
optimized for maximal AUC.
In the next step, the models were built using additional
features (e.g., number and window-specific proportion of
blood tests performed in a specific window), where a
significant increase in all evaluation metrics can be observed,
indicating that the features describing the number and
proportion of blood tests in a specific time window represent
an important contribution to the model. *e mean AUC
value of the full lasso model (FLM) increased to 0.954 and
was surprisingly slightly higher for pmax set to 50 to 0.956,
whereas AUPRC increased from 0.819 to 0.821 in the same
way. *is represents a gain (∼1%) in AUC compared to the
BLM.
3.3. Results Using the Price Penalized Model. *e next ex-
periment price penalizedmodel (PPM) aimed at producing a
more cost-effective model by taking into account the price of
blood tests. When comparing the unrestricted PPM and the
model restricted to maximum 20 features, a slight decrease
in all evaluation metrics can be observed. Interestingly, also
the mean number of features included in unrestricted PPM
decreases from 32.6 features in the FLM to 25.2 features in
the PPM, which points to the fact that two or more tests
might have been replaced by single more-expensive tests.
*e restriction of the model to a maximum number of
features is even more reasonable, although a slight decrease
Table 2: Summary of SSI classification results for basic lasso model (BLM), full lasso model (FLM), price penalized model (PPM), and
XGBoost predictive model.
Model CRP BLM BLM(pmax � 20)
FLM FLM(pmax � 50)




4.4 35.6 12.3 32.6 28.4 25.2 12.1
[4.2, 4.6] [33.1, 38.2] [11.8, 12.9] [30.2, 35.0] [27.1, 29.6] [22.9, 27.5] [11.7, 12.6]
AUC 0.797 0.947 0.943 0.954 0.956 0.952 0.951 0.954[0.788, 0.806] [0.944, 0.951] [0.940, 0.947] [0.951, 0.958] [0.953, 0.959] [0.948, 0.955] [0.948, 0.954] [0.951, 0.957]
AUPRC 0.550 0.809 0.810 0.819 0.821 0.813 0.817 0.829[0.532, 0.568] [0.798,0.821] [0.799,0.822] [0.807, 0.830] [0.810, 0.832] [0.801,0.824] [0.805–0.828] [0.818, 0.839]
*reshold 0.204 0.188 0.179 0.221 0.216 0.191 0.171 0.245[0.201–0.207] [0.183–0.193] [0.176–0.182] [0.216–0.226] [0.211–0.220] [0.186–0.196] [0.167–0.175] [0.237–0.252]
Sensitivity 0.699 0.858 0.856 0.856 0.860 0.868 0.874 0.836[0.683, 0.715] [0.846, 0.870] [0.844, 0.868] [0.845, 0.867] [0.848, 0.871] [0.857, 0.879] [0.864, 0.885] [0.824, 0.847]
Specificity 0.799 0.895 0.885 0.902 0.901 0.888 0.876 0.919[0.791, 0.808] [0.891, 0.900] [0.879, 0.891] [0.896, 0.907] [0.895, 0.906] [0.882, 0.894] [0.869, 0.882] [0.915, 0.924]
PPV 0.469 0.673 0.654 0.688 0.687 0.663 0.641 0.724[0.454, 0.483] [0.661, 0.684] [0.640, 0.667] [0.673, 0.703] [0.673, 0.701] [0.647, 0.678] [0.628, 0.655] [0.710, 0.739]
NPV 0.914 0.962 0.961 0.962 0.962 0.964 0.966 0.957[0.910, 0.919] [0.958, 0.965] [0.958, 0.964] [0.958, 0.965] [0.959, 0.966] [0.961, 0.967] [0.963, 0.969] [0.954, 0.960]


































Nr. features 4 10 21 29 29 40 37 34 33 44 34
AUC 0.966 0.967 0.961 0.961 0.961 0.961 0.961 0.962 0.961 0.962 0.962
AUPRC 0.882 0.872 0.880 0.874 0.874 0.875 0.873 0.873 0.871 0.877 0.874
Sensitivity 0.920 0.920 0.920 0.920 0.920 0.900 0.900 0.900 0.900 0.900 0.900
Specificity 0.871 0.865 0.893 0.893 0.893 0.920 0.910 0.900 0.900 0.920 0.900
PPV 0.667 0.657 0.701 0.701 0.701 0.780 0.763 0.734 0.726 0.763 0.726
NPV 0.975 0.975 0.975 0.975 0.975 0.971 0.970 0.970 0.970 0.970 0.970
Nr. predicted cases 69 70 65 65 65 59 61 62 62 59 62
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in evaluation metrics can be expected. *e highest decrease
was observed in PPV, i.e., by more than 2%, and the other
metric decreased by less than 1%. However, the mean
number of features used in the restricted PPM decreased to
12.1. Additionally, we calculated the provisional costs of all
tests that would need to be performed in case of the FLM in
comparison to PPM. *e costs of all tests recorded for
patients in the validation set of 100 cross-validation runs
were calculated (simulating 18,100 patients). A marginal
cost reduction of only 4.2% was observed in unrestricted
FLM vs. PPM. However, in case of limiting the maximal
number of features to 20, a significant cost reduction of
48.1% was obtained, reducing the costs for FLM from
25,783,747 NOK to 12,401,982 NOK needed for PPM.
4. Results Using Extreme Gradient Boosting of
Decision Trees
Finally, the extreme gradient boosting of decision trees was
tested on a full set of features. *e best results were obtained
using an ensemble of 20 decision trees with a maximum
depth of 10. *e mean AUC value of 0.954 is comparable to
the FLM with a mean number of features at 32.6.
4.1. Model Selection. However, the FLM was chosen on the
basis of lower complexity and higher interpretability. *e
most frequent features in 100 iterations of the FLM eval-
uation and their signs of regression coefficients are shown in
Table 4. It can be observed that 8 features are included in the
model for most of the iterations (above 95%). More pre-
cisely, CRP in the medium window is the only feature for
which the mean parameter value was selected. *is makes
sense also from a medical point of view, since CRP is one of
the most common indicators of systemic inflammation and
is often increased due to infection. *ree other selected
features from the medium window are related to the number
of performed tests (leukocytes and sodium), five features
present the proportional number of respective tests (short
window hemoglobin, medium window thrombocytes, he-
moglobin, and long window leukocytes), and the final one
presents the slope of albumin in the long window. *e
number and proportion of performed tests probably relate to
the attending physician’s instinct or experience. More
specifically, the number of tests for counting leukocytes
could indicate the attending physician’s assumption of a
possible infection.
4.2. Model Testing. *e final models, built on the model
development data set (n � 909), were evaluated using the
test set (n � 228) with 50 positive cases for FLM using
different pmax values. *e optimal result in terms of AUC/
AUPRC was surprisingly at pmax � 10 and pmax � 20 with
some performance metrics better with pmax � 10, like
AUPRC of 0.882, specificity of 0.971, and PPV 0.667; other
were better with pmax � 20, like AUC of 0.967 (Table 3).
Additionally, it can be seen that, at pmax � 20, six more
predictors were selected with a total of 10 predictors than
at pmax � 10 and more positively predicted cases were
predicted with a total of 70 (Table 3). A graphical rep-
resentation of test set evaluation in terms of AUC and
PPV at different pmax values is also shown (Figure 2).
When looking at selected features, we can see that four
positive predictors were selected in all models: hamo-
globin and leukocytes number of test in the medium
window, potassium number of tests in the medium
window, and thrombocytes proportional number of tests
in the medium window.
5. Discussion
Norway has one of the highest rates of SSIs in the gastro-
intestinal tract (GIT), which is consistent with a very high
incidence of colorectal cancer that is the most common
cause of GIT surgery [12]. Our results support the practical
applicability of a combination of blood test results and the
temporal testing pattern in predicting SSIs in a clinical
setting. More specifically, in addition to the values of a given
blood test per se (e.g., CRP), our findings demonstrate that
additional extracted features (e.g., number and window-
specific proportion of blood tests performed in a specific
window) can be very informative with regard to predicting
SSIs.
We are aware that the manual selection of temporal
windows may have introduced some bias in evaluation of
the solutions and is a limitation of the study, but we
believe that the sample is big enough to reflect the trends
present also in the test set. Future work will improve the
selection process with an automatic selection process. One
general algorithm considered is the maximum distance
between windows approach. A two-step approach, where
we firstly select the best partitioning on k temporal
windows in terms of the highest score function and
Table 4: Upper half of the total number of features selected (above
50%) and their coefficient’s signs in 100 repetitions of 10-fold cross-
validation for FLM.
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secondly we repeat the ­rst step on all di¡erent sizes of
partitionings, which gives us the optimal partitioning.
More precisely, we de­ne a distance function for di¡er-
entiating of daily mean values curves with CI between
patients who develop SSI and those who do not for a ­xed
window length of a selected blood test, for example, dij
would note a distance function between days i and j. Next,
we de­ne a k-partitioning of the whole window length as
S1, . . . , Sk for S1 ∪ . . . ∪ Sk  Ω, Si ∩ Sj  ∅, i≠ j and
the score function for this partitioning as f(dS1, . . . , dSk),
where the f function could be as simple as multiplication
of distance functions. For all the k-partitionings of a ­xed
k≤ n, we then select the k-partitioning with the highest
score function value. e second step is using the ­rst step
for each of 1≤ k≤ n partitionings, giving us the optimal
partitioning. One drawback of such an approach could be
computational intensity, since for n 60-day window and
k  3 partitions, a total of 34,220 partitions of a speci­c
blood test are possible.
Since testing is mostly guided by judgment of clinicians,
which is in turn based on patient history, clinical signs,
previous blood tests, results of diagnostic imaging, general
patient observation etc., we believe that our choice to in-
clude information on testing patterns enabled us to in-
directly include judgment by expert clinicians into our
predictive model. Moreover, we believe that, due to its
intuitive nature, clinicians could easily relate to and accept
our predictive model.
With regard to values, among all tests, CRP values above
normal played a predominant role in our model. From a
mechanistic point of view, increased CRP is highly sug-
gestive of an underlying in¥ammatory process. Our ­ndings
indicate that, also in the period preceding operation, a
higher-than-normal CRP value raises the probability that a
patient will develop SSI. e mechanistic substrate for this
observation might be that the underlying in¥ammatory
process indicates an increased susceptibility toward in-
fections or even contributes to their development.
Recently, it has been suggested that signs of preoperative
in¥ammation may predict postoperative infectious com-
plications, speci­cally in patients undergoing colorectal
surgery [30, 44, 45]. At least 4 out of our 6 positive predictors
may be viewed as markers of in¥ammation, namely, the
mean CRP value in the medium window, leukocytes with
high proportion of abnormal values/number of tests in the
long window, and leukocytes number of tests in the medium
window. Local in¥ammation impairs the healing process,
and systemic in¥ammation interferes with the immune
response. e fact that our positive predictors pointed to
in¥ammation or a suspected in¥ammation in the long or
medium period might suggest that, during this time, they
were a better marker of chronic in¥ammation than just
shortly before the procedure. e predictive roles of
thrombocytes and potassium remain to be con­rmed and
explained in future studies. However, it is tempting to
speculate that low thrombocyte counts may directly impede
the healing process, whereas high numbers may indicate or
even modulate in¥ammation [46], and that the number of
potassium concentration tests re¥ects more fragile patients
with disturbed water and electrolyte homeostasis, e.g., due to
abnormal ADH secretion or kidney disease.
Our study included only GIT surgery patients, mainly
due to the high risk of SSIs in this group [6]. It is rea-
sonable to speculate that a similar predictive model could
be developed and used for other types of surgeries. A
recent study indeed found that CRP, together with pre-
operative levels of albumin, hemoglobin, and signs of mild
or moderate kidney failure, was signi­cantly associated
with the odds of SSI in a diverse group of patients un-
dergoing general, oncologic, trauma, and vascular surgery
procedures [32]. Even so, it remains to be investigated



























































Figure 2: Model testing with regard to parameter pmax in terms of AUC with number of selected predictors (a) and PPV with number of
correctly classi­ed cases out of 50 (b).
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patients, inclusion of information on testing patterns will
result in better predictive models.
Let us now discuss the wider importance of studies
similar to ours that try to shed more light on the predictive
power of preoperative blood tests in prediction of SSI. It is
generally accepted that effective guidelines are key in
prevention of SSI. On one hand, clinical guidelines pave the
way for specific tests that need to be conducted in a certain
patient prior to a specific surgery. On the other hand, the
demand for specific tests, which are not always even
conducted by the hospital where the patient is hospitalized,
mandates the overall cost for a battery of tests. In the case of
preoperative blood tests, of which none costs more than 2€
per measurement per patient, we can easily calculate that
even a battery of 10 tests conducted three times prior to
surgery (which in most cases costs at least a couple of
1000€, depending on surgery type) would cost only 60€.
*is means we can probably perform as many blood tests as
we want and still provide a cheaper solution for the in-
surance companies (and hospitals) compared to compli-
cations and increasing costs connected with SSI. On the
other hand, by preventing SSI preoperatively, we at the
same time also prevent unnecessary patient complications,
the lowered quality of life, and finally, prolonged stays of
the respective patients’ socioeconomic environment.
Longer hospitalization times on one hand tend to induce
longer socioeconomic reintegration times, especially in the
elderly, while on the other hand, they lead to significantly
increased overall treatment costs.
6. Conclusions
Our solution is based on abstraction of preoperative blood
test data and use of L1-penalized logistic regression to
predict SSI. Additional solutions were developed to im-
prove the model’s practical interpretability (for the treating
clinician as well as for the medical informatician) and to
include the cost-effectiveness aspect. *e model with the
best solution clearly indicates that a specific and easy in-
terpretable SSI-related feature (CRP) has to be paired with
rather indirect features related to the available temporal
data (number, proportion of tests, etc.). In our opinion, this
nicely captures the “treating clinician’s suspicion” based on
the overall patient evaluation over the course of the period
preceding surgery. *e model that included CRP only
resulted in an AUC of ∼80%, whereas models that addi-
tionally included the indirect features reached an AUC of
∼95%.
Considering the high incidence of SSI (especially related
to GIT surgery) and the continuous efforts of EU officials to
decrease this value, our model could contribute to new
guidelines in the field of preoperative SSI prevention and
surveillance.
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